Form 4: Director Myla Lai Goldman Acquires WST Shares

Director Myla Lai Goldman acquired 791 restricted stock units of West Pharmaceutical Services, Inc. as part of director compensation.

Summary

• Director Myla Lai Goldman received an award of 791 restricted stock units (RSUs) on May 4, 2026.
• The transaction was valued at $0 per share, representing a standard equity grant for board service.
• Following this transaction, the director's total beneficial ownership in West Pharmaceutical Services, Inc. (WST) increased to 20,434.587 shares.
• The RSUs are scheduled to vest in full on the date of the next annual shareholder meeting.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial outlook.

Positives

• Alignment of director interests with shareholders through increased equity ownership.
• Standardized compensation structure for outside directors.

Negatives

• None identified.

Risks

• None identified.

Future Outlook

The restricted stock units are set to vest in full on the date of the next annual shareholder meeting and will be distributable under the company's Deferred Compensation Plan for Outside Directors.

Industry Context

StockSavvy.ai notes that director equity grants are standard corporate governance practices designed to incentivize long-term board commitment and align director incentives with shareholder value creation.

Comparison to Industry Standards

• The grant of restricted stock units to non-employee directors is consistent with standard compensation practices for S&P 500 and mid-cap healthcare companies.
• The vesting schedule tied to the annual shareholder meeting is a common practice for board-level equity compensation.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard director compensation event.

Next Steps

• Vesting of the 791 restricted stock units upon the next annual shareholder meeting.

Key Dates

Keywords

West Pharmaceutical Services, WST, Form 4, Insider Trading, Director Compensation, Equity Grant